Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChenavari Toro Regulatory News (TORO)

Share Price Information for Chenavari Toro (TORO)

Share Price is delayed by 15 minutes
Get Live Data
0.5425    0.00 (0.00%)
Bid:
0.53
Ask:
0.555
Spread: 0.025 (4.717%)
Market Cap: €171.00m
TORO Live PriceLast checked at - London Stock Exchange

Intraday Chenavari Toro Share Chart

Total Voting Rights

6 Aug 2019 07:00

RNS Number : 9655H
Chenavari Toro Income Fund Limited
06 August 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

THIS ANNOUNCEMENT INCLUDES INSIDE INFORMATION

 

CHENAVARI TORO INCOME FUND LIMITED (the "Company")6 August 2019

 

 

Total voting rights

Following the Tender Offer where 9,331,940 Shares were validly tendered, the remaining Shares in issue total 361,450,000, of which 50,264,733 Shares are held in treasury. Shares held in treasury carry no voting rights, therefore the total number of voting rights in the Company will be 311,185,267. This figure may be used by shareholders and other investors as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 Enquiries:

 

Chenavari Investment Managers: Guy Goyard - 020 7245 4672, Kirstie Sumarno - 020 7259 3600J.P. Morgan Cazenove: William Simmonds - 020 7742 4000

 

 

This announcement is not an offer to sell or a solicitation of any offer to buy the securities of Chenavari Toro Income Fund Limited (the "Company") in the United States, Australia, Canada, Japan, The Republic of South Africa or in any other jurisdiction where such offer or sale would be unlawful.

 

This communication is not for publication or distribution, directly or indirectly, in or into the United States of America. This communication is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

 

The information contained in this announcement is given at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment. In particular, the proposals referred to herein are tentative and are subject to material updating, revision and amendment. No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.

 

The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events and in certain cases can be identified by the use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue", "target", "believe" (or the negatives thereon) or other variations thereon or comparable terminology. These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company, including, among other things, the development of its business, trends in its operating industry, and future capital expenditures and acquisitions. In light of these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur. Each of the Company its affiliates and their respective officers, employees and agents expressly disclaim any and all liability which may be based on this announcement and any errors therein or omissions therefrom.

 

This announcement does not constitute or form part of, and should not be construed as, any offer or invitation or inducement for sale, transfer or subscription of, or any solicitation of any offer or invitation to buy or subscribe for or to underwrite, any share in the Company or to engage in investment activity (as defined by the Financial Services and Markets Act 2000) in any jurisdiction nor shall it, or any part of it, or the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction.

 

J.P. Morgan Cazenove is authorised and regulated in the United Kingdom by the Financial Conduct Authority. J.P. Morgan Cazenove is acting as Corporate Broker to the Company and no one else in connection with the proposals described in this announcement, and will not be responsible to anyone other than the Company for providing the protections afforded to clients of J.P. Morgan Cazenove or for affording advice in relation to any transaction or arrangement referred to in this announcement. This announcement does not constitute any form of financial opinion or recommendation on the part of J.P. Morgan Cazenove or any of its affiliates and is not intended to be an offer, or the solicitation of any offer, to buy or sell any securities.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREAKPSEAFNEFF
Date   Source Headline
18th Jun 20255:00 pmRNSCompany Factsheet Available
17th Jun 20257:00 amRNSNet Asset Value(s)
6th Jun 20255:00 pmRNSShares in Issue
23rd May 20255:00 pmRNSCompany Factsheet Available
21st May 20255:00 pmRNSDirectorate Change
16th May 20255:01 pmRNSNet Asset Value(s)
16th May 20255:00 pmRNSDirector Declaration
15th May 20255:00 pmRNSScrip Dividend Election Price
30th Apr 20257:01 amRNSCompany Factsheet Available
30th Apr 20257:00 amRNSDividend Declaration
28th Apr 20255:00 pmRNSNet Asset Value(s)
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20256:30 pmRNSCompany Factsheet Available
31st Mar 20255:00 pmRNSNet Asset Value(s)
14th Mar 20251:00 pmRNSResult of AGM
7th Mar 20255:00 pmRNSShares in Issue
6th Mar 20255:00 pmRNSCompany Factsheet Available
26th Feb 20255:00 pmRNSNet Asset Value(s)
14th Feb 20257:00 amRNSNotice of AGM
13th Feb 20255:00 pmRNSScrip Dividend Election Price
11th Feb 202511:00 amRNSQuarterly Investor Webinar
31st Jan 20257:00 amRNSCompany Factsheet Available
30th Jan 20257:00 amRNSDividend Declaration
23rd Jan 20257:00 amRNSNet Asset Value(s)
2nd Jan 20257:00 amRNSTotal Voting Rights
31st Dec 202412:30 pmRNSCompany Factsheet Available
24th Dec 20247:01 amRNSNet Asset Value(s)
24th Dec 20247:00 amRNSAnnual Report and Audited Financial Statements
6th Dec 20245:00 pmRNSShares in Issue
28th Nov 20245:00 pmRNSCompany Factsheet Available
18th Nov 20245:00 pmRNSNet Asset Value(s)
14th Nov 20245:00 pmRNSScrip Dividend Election Price
7th Nov 20245:00 pmRNSShares in Issue
31st Oct 20245:00 pmRNSCompany Factsheet Available
31st Oct 20247:00 amRNSQuarterly Investor Webinar
30th Oct 20247:00 amRNSDividend Declaration
25th Oct 20245:00 pmRNSNet Asset Value(s)
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 20245:00 pmRNSCompany Factsheet Available
25th Sep 20245:00 pmRNSNet Asset Value(s)
6th Sep 20245:00 pmRNSShares in Issue
29th Aug 20245:00 pmRNSCompany Factsheet Available
21st Aug 20245:00 pmRNSNet Asset Value(s)
15th Aug 20245:00 pmRNSScrip Dividend Election Price
30th Jul 20247:00 amRNSDividend Declaration
29th Jul 20247:00 amRNSQuarterly Investor Webinar
24th Jul 20247:00 amRNSCompany Factsheet Available
19th Jul 20245:00 pmRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
28th Jun 20245:00 pmRNSCompany Factsheet Available

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.